Psychiatry

The selective serotonin inverse agonist, previously approved for Parkinson symptoms, could soon seek FDA approval as an adjunctive therapy.

The FDA approved the Monarch electronic Trigeminal Nerve Stimulation based on the findings of a trial involving children aged 7-12 years old.

A new study of 55 million insured young adults in the US found that major depression, type 2 diabetes, and other conditions are becoming more prevalent among them.

A retroactive review of patients referred to a psychiatric consultant found that most patients left with a different diagnosis.

A new study shows that a history of anxiety and depression drive suicidal thoughts in students, but having a significant other may limit such thoughts.

Investigators reviewed 347 published articles and found that physician suicide, while a significant problem, is poorly understood and identified multiple possible interventions that could help.

Sleep habits are an overlooked aspect of primary care visits, despite the prevalence and burden of conditions such like insomnia on the general population.

Both long-acting injectable treatments produced statistically significant and clinically meaningful improvements.

A study of 41 patients in a single center show novel results for the recently-approved treatment-resistant depression therapy.

An extended-release, subcutaneous injection form of buprenorphine (Sublocade) demonstrated long-term efficacy and safety results.

The three-minute device complements the company's marketed TMS devices which provide care over 37.5 and 19 minutes per session.

Before the new treatment-resistant depression therapy reaches the market, Iosifescu anticipates its benefits and limitations in real-world patients.

A fourth phase 3 study of investigational drug SPN-812 demonstrated a significant decrease in ADHD-RS-5 scores compared to placebo.

Higher exposure to air pollutants, especially NO2 and NOx, was found to be associated with greater odds of psychotic experiences in adolescents.

Just 7 other states, and the District of Columbia, have passed such a law before. The bill's parameters are similar to that of Hawaii's, which passed its own law last year.

How care providers can improve their perspective and better their stress with some volunteer work where it's needed most.

First RCT to determine the efficacy of wearable digital intervention to improve social behavior of children with autism spectrum disorder.

Study of Danish children finds that onset of maternal mental illness increases a child's risk of not completing primary education.

The 60-hour intravenous therapy becomes the first drug indicated for postpartum depression.

Observed data from a 96,000-plus participant survey found the popularized cigarette alternative is also associated with a greater risk of depression.

A review of suicide prediction models reveals limited practical application on larger populations.

Despite previous observations that high-quality diet correlates to lower depression symptoms, new results paint a different picture.

In a rare clinical trial, stem cell transplantation appeared to provide greater protection against MS progression than DMT.

If approved by the FDA later this year, the Allergan drug would become the first oral CGRP receptor antagonist approved for acute migraine treatment.

One of the pioneer investigators of ketamine for depression explains what its recent approval for a severe form of the condition means for patients running out of options.

The therapy becomes the first novel mechanism of action-driven drug approved for depression in 30 years.

The prevalence of anxiety, depression, and ADD was higher in patients with this excessive sweating disorder than the general population.

The CNS stimulant was approved as an extended-released capsule intended to serve as a first-line ADHD therapy.

A large retrospective study of patients with acne found no significant association between isotretinoin exposure and depression.

Investigators found that the prevalence of asthma in patients with opioid dependence was more than double the national prevalence.